Whither tobacco product regulation?

Tobacco Control

Volumn 21, Issue 2, 2012, Pages 221-226

  McNeill, Ann ^a   Hammond, David ^b   Gartner, Coral ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF WATERLOO   (Canada)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HARM REDUCTION; HEALTH PROMOTION; HUMAN; LEGAL ASPECT; METHODOLOGY; PRODUCT SAFETY; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TOBACCO INDUSTRY;

CONSUMER PRODUCT SAFETY; HARM REDUCTION; HEALTH PROMOTION; HUMANS; SMOKING; SMOKING CESSATION; TOBACCO INDUSTRY; TOBACCO USE DISORDER; TOBACCO, SMOKELESS;

EID: 84857253928     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tobaccocontrol-2011-050258     Document Type: Article

References (51)

1. Balfour DJ. The neuronal pathways mediating the behavioural and addictive properties of nicotine. Handb Exp Pharmacol 2009;192:209-33.
2. Kozlowski LT, Frecker RC, Khouw V, et al. The misuse of 'less-hazardous' cigarettes and its detection: hole-blocking of ventilated filters. Am J Public Health 1980;70:1202-3.
3. WHO Framework Convention on Tobacco Control. Geneva: World Health Organization, 2005.
4. Conference of the Parties to the WHO Framework Convention on Tobacco Control. Draft guidelines for the implementation of Articles 9 and 10 of the WHO Framework Convention on Tobacco Control. Agenda Item 5.2. FCTC/COP/4/6Rev.1. Uruguay, 2010.
5. Rodriguez J, Jiang R, Johnson WC, et al. The association of pipe and cigar use with cotinine levels, lung function, and airflow obstruction: a cross-sectional study. Ann Intern Med 2010;152:201-10.
6. Royal College of Physicians of London. Nicotine Addiction in Britain. A report of the Tobacco Advisory Group of the Royal College of Physicians. London: Royal College of Physicians of London, 2000.
7. National Cancer Institute. Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. Smoking and Tobacco Control Monograph 13. Bethseda, MD: National Cancer Institute, 2001.
8. Muscat JE, Takezaki T, Tajima K, et al. Charcoal cigarette filters and lung cancer risk in Aichi Prefecture, Japan. Cancer Sci 2005;96:283-7.
9. Action on Smoking or Health. Briefing on Plain Packaging. 2010. http://www.ash.org.uk/files/documents/ASH_699.pdf (accessed 22 Apr 2010).
10. US Department of Health and Human Services, Food and Drug Administration. AFR Parts 16 and 1107. Docket No. FDA-2010-N-0646. Document issued on 5 January 2011. http://www.fda.gov/downloads/TobaccoProducts/ResourcesforYou/ForIndustry/UCM238885.pdf (accessed 23 Apr 2011).
11. US Department of Health and Human Services, Food and Drug Administration, Center for Tobacco Control Products. Guidance for Industry and FDA Staff. Section 905(j) Reports: Demonstrating Substantial Equivalence for Tobacco Products. Document issued on 5 January 2011. http://www.fda.gov/downloads/TobaccoProducts/GuidanceComplianceRegulatoryInformation/UCM239021.pdf (accessed 23 Apr 2011).
12. Stratton K, Shetty P, Wallace R, et al, eds. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington DC: National Academy Press, 2001.
13. Breland AB, Kleykamp BA, Eissenberg T. Clinical laboratory evaluation of potential reduced exposure products for smokers. Nicotine Tob Res 2006;8:727-38.
14. Wayne GF. Potential reduced exposure products (PREPs) in industry trial testimony. Tobacco Control 2006;15(Suppl 4):iv90-7.
15. Bogen K, Biener L, Garrett CA, et al. Surveillance indicators for potential reduced exposure products (PREPs): developing survey items to measure awareness. Harm Reduct J 2009;6:27.
16. American Society for Testing and Materials International ASTM E2187-09. Standard test method for measuring the ignition strength of cigarettes. West Conshohocken, Pennsylvania: ASTM International, revised 2009.
17. National Fire Protection Association. The Smoking-Material Fire Problem. Massachusetts, 2010. http://www.nfpa.org/assets/files//PDF/OS.Smoking.pdf (accessed 22 Apr 2011).
18. World Health Organization. The Scientific Basis of Tobacco Product Regulation: second report of a WHO Study Group. WHO Technical Report Series, No.951. Switzerland: WHO, 2008.
19. Pankow JF, Watanabe KH, Toccalino PL, et al. Calculated cancer risk for conventional and 'potentially reduced exposure product' cigarettes. Cancer Epidemiol Biomarkers Prev 2007;16:584-92.
20. Scientific Committtee on Emerging and Newly Identified Health Risks (SCENIHR). Addictiveness and Attractiveness of Tobacco Additives. Brussels: Belgium, Directorate-General for Health and Consumers, European Commission, 2010.
21. Tobacco Products Scientific Advisory Committee (TPSAC) of the Centre for Tobacco Products of the Food and Drug Administration. Report and Recommendations on the Impact of the Use of Menthol in Cigarettes on the Public Health. 2011. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/TobaccoProductsScientificAdvisoryCommittee/UCM247689.pdf (accessed 22 Apr 2011).
22. Carter LP, Stitzer ML, Henningfield JE, et al. Abuse liability assessment of tobacco products including Potential Reduced Exposure Products (PREPs). Cancer Epidemiol Biomarkers Prev 2009 18:3241-62.
23. Henningfield JE, Hatsukami DK, Zeller M, et al. Conference on abuse liability and appeal of tobacco products: conclusions and recommenations. Drug Alcohol Depend 2011;116:1-7.
24. Hatsukami DK, Perkins KA, Lesage MG, et al. Nicotine reduction revisited: science and future directions. Tob Control 2010;19:e1-10.
25. Panzano VC, Wayne GF, Pickworth WB, et al. Human electroencephalography and the tobacco industry: a review of internal documents. Tob Control 2010;19:153-9.
26. Hatsukami DK, Kotlyar M, Hertsgaard LA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction 2010;105:343-55.
27. Hall WD, West R. Thinking about the unthinkable: a de facto prohibition on smoked tobacco products. Addiction 2008;103:873-4.
28. International Agency for Research on Cancer (IARC). Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines. Lyon, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon: WHO IAC, Vol 89, 2007.
29. Stepanov I, Jensen J, Hatsukami D, et al. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res 2008;10:1773-82.
30. Stepanov I, Villalta PW, Knezevich A, et al. Analysis of 23 polycyclic aromatic hydrocarbons in smokeless tobacco by gas chromatography-mass spectrometry. Chem Res Toxicol 2010;23:66-73.
31. World Health Organization. The Scientific Basis of Tobacco Product Regulation: third report of a WHO Study Group. WHO Technical Report Series, No.955. Switzerland: WHO, 2009.
32. Foulds JL, Ramstrom L, Burke M, et al. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003;12:349-59.
33. Hammond D, Dockrell M, Arnott D, et al. Cigarette pack design and perceptions of risk among UK adults and children. Eur J Pub Health 2009;19:631-7.
34. Hecht SS, Yuan JM, Hatsukami D. Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. Chem Res Toxicol 2010;23:1001-8.
35. O'Connor RJ. Postmarketing surveillance for 'modified-risk' tobacco products. Nicotine Tob Res. Published Online First: 20 January 2011. doi:10.1093/ntr/ntq243.
36. WHO Framework Convention on Tobacco Control. Elaboration of guidelines for implementation of Articles 9 and 10 of the WHO Framework Convention on Tobacco Control. Progress report of the working group. FCTC/COP/3/6. Third Session of the Conference of the Parties. 2008. http://apps.who.int/gb/fctc/PDF/cop3/FCTC_COP3_6-en.pdf (accessed 22 Apr 2011).
37. Electronic Model Tobacco Control. Project by RIVM funded by European Commission. Rijksinstituut voor Volksgezondheid en Milieu: RIVM. http://ec.europa.eu/eahc/projects/database.html?prjno1/42007312 (accessed 23 Apr 2011).
38. O'Connor RJ, Wilkins KJ, Caruso RV, et al. Cigarette characteristic and emission variations across high-, middle- and low-income countries. Public Health 2010;124:667-74.
39. WHO Framework Convention on Tobacco Control. Work in progress in relation to Articls 9 and 10 of the WHO Framework Convention on Tobacco Control. FCTC/ COP/4/INF.DOC./2. Fourth Session of the Conference of the Parties. 2010. http://apps.who.int/gb/fctc/PDF/cop4/FCTC_COP4_ID2-en.pdf (accessed 23 Apr 2011).
40. Hatsukami DK, Biener L, Leischow SJ, et al. Tobacco and nicotine product testing. Nicotine Tob Res. Published Online First: 6 April 2011. doi:10.1093/ntr/ntr027.
41. Kozlowski LT, Straser AA, Giovino GA, et al. Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction. Tob Control 2001;10:201-3.
42. Le Houezec J, McNeill A, Britton J. Tobacco, nicotine and harm reduction. Drug Alcohol Rev 2011;30;119-23.
43. Gartner C, Hall W, McNeill A. Harm reduction policies for tobacco. In: Rhodes T, Hedrich D (eds) Harm Reduction: Evidence, Impacts and Challenges. Portugal: EMCDDA, 2010
44. Kozlowski LT, O'Connor RJ, Edwards BQ. Some practical points on harm reduction: what to tell your lawmaker and what to tell your brother about Swedish snus. Tob Control 2003;12:372-3.
45. Gartner CE, Hall WD, Chapman S, et al. Should the health community promote smokeless tobacco (snus) as a harm reduction measure? PLoS Med 2007;4:1703-4.
46. Sugarman S. No more business as usual enticing companies to sharply lower the public health costs of the products they sell. Public Health 2009;123:275-9.
47. Hall W, Gartner C. Supping with the Devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products. Public Health 2009;123:287-91.
48. Yamin CK, Bitton A, Bates DW. E-Cigarettes: a rapidly growing internet phenomenon. Ann Intern Med 2010;153:607-9.
49. Medicines and Healthcare Products Regulatory Authority (MHRA). The Regulation of Nicotine Containing Products. 2011. http://www.mhra.gov.uk/Publications/Consultations/Medicinesconsultations/MLXs/CON065617 (accessed 23 Apr 2011).
50. Freedom Organisation for the Right to Enjoy Smoking Tobacco (FOREST). http://wwwforestonline.org/ (accessed 23 Apr 2011).
51. Borland R. A strategy for controlling the marketing of tobacco products: a regulated market model. Tob Control 2003;12:374-82.